A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group

Motohiro Kato(The University of Tokyo), Katsuyoshi Koh(Saitama Children's Medical Center), Keizo Horibe(National Hospital Organization), Kenichiro Watanabe(University Hospital of Geneva), Yoshiyuki Kosaka(Kobe Gakuin University), Takashi Taga(Erasmus MC), Takao Deguchi(Mie University), Masashi Sanada(Nagoya Medical Center), Atsushi Manabe(St. Luke's International Hospital), Yuka Iijima‐Yamashita(Nagoya Medical Center), Akiko Kada(National Hospital Organization), Kenichi Anami(Fukuoka University), Nao Yoshida(Nihon University), Souichi Adachi(Kyoto University), Yasuhiro Okamoto(Kagoshima University), Nobutaka Kiyokawa(National Center For Child Health and Development), Masakatsu Yanagimachi(Kanagawa Children's Medical Center), Chihaya Imai(University of Toyama), Yoshiko Hashii(The University of Osaka), Yuki Yuza(Tokyo Metropolitan Children's Medical Center), Tomohiko Taki(Kyorin University), Akiko Saito(Nagoya University Hospital), Takashi Fukushima(University of Tsukuba), Toshihiko Imamura(Kyoto Prefectural University of Medicine), Atsushi Satō(National Cancer Center Hospital East), Kentaro Oki(National Center For Child Health and Development)
Blood
November 2, 2023
Cited by 3


Related Papers